Literature DB >> 2991502

Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine.

J D Leander, R L Zerbe, J C Hart.   

Abstract

The effects of agonists at kappa, mu and delta opioid receptors were determined on vasopressin levels in water-deprived rats. Bremazocine and U-50, 488 (kappa agonists) markedly suppressed vasopressin levels, whereas morphine and methadone (mu agonists) and metkephamid (a mixed mu and delta agonist) did not suppress vasopressin levels. Likewise, clonidine, a potent diuretic in normally hydrated rats, did not clearly suppress vasopressin levels. Metkephamid was shown to have a modest diuretic effect in normally hydrated rats but not in water-deprived rats. The diuretic effects of bremazocine were blocked completely by simultaneous treatment with desmopressin, a synthetic vasopressin-like analog. Desmopressin also blocked the diuretic effect of a waterload, but only partially attenuated the diuretic effect of clonidine. These results support the hypothesis that kappa opioid agonists produce a diuretic effect by suppressing plasma levels of vasopressin, and at higher doses produce a pattern of urination similar to animals lacking vasopressin. By comparison, mu and delta opioid agonists have little effect on vasopressin levels in water-deprived rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991502

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Kappa-opioid-induced changes in renal water and electrolyte management and endocrine secretion.

Authors:  N Ashton; R J Balment; T P Blackburn
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

2.  Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice.

Authors:  Girish R Chopda; Viraj Parge; Ganesh A Thakur; S John Gatley; Alexandros Makriyannis; Carol A Paronis
Journal:  J Pharmacol Exp Ther       Date:  2016-05-26       Impact factor: 4.030

3.  Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man.

Authors:  H J Kramer; W Uhl; B Ladstetter; A Bäcker
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

4.  Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics.

Authors:  Jacob K Meariman; Jane C Sutphen; Juan Gao; Daniel R Kapusta
Journal:  Hypertension       Date:  2021-12-02       Impact factor: 10.190

5.  Cloning and pharmacological characterization of a rat kappa opioid receptor.

Authors:  F Meng; G X Xie; R C Thompson; A Mansour; A Goldstein; S J Watson; H Akil
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Mechanism of diuretic action of spiradoline (U-62066E)--a kappa opioid receptor agonist in the human.

Authors:  G H Rimoy; N K Bhaskar; D M Wright; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

7.  Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.

Authors:  S L Walsh; A E Chausmer; E C Strain; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2007-10-02       Impact factor: 4.530

8.  Renal responses produced by microinjection of the kappa opioid receptor agonist, U50-488H, into sites within the rat lamina terminalis.

Authors:  Cynthia Franklin; Lourdes Fortepiani; Tin Nguyen; Yolanda Rangel; Randy Strong; Helmut B Gottlieb
Journal:  Pharmacol Res Perspect       Date:  2015-02-10

9.  Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITY.

Authors:  Chongguang Chen; Alex H Willhouse; Peng Huang; Nora Ko; Yujun Wang; Bin Xu; Lan Hsuan Melody Huang; Brigitte Kieffer; Mary F Barbe; Lee-Yuan Liu-Chen
Journal:  eNeuro       Date:  2020-07-23

10.  Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?

Authors:  Caroline M Kopruszinski; Robson Vizin; Moe Watanabe; Ashley L Martinez; Luiz Henrique Moreira de Souza; David W Dodick; Frank Porreca; Edita Navratilova
Journal:  J Headache Pain       Date:  2022-09-30       Impact factor: 8.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.